Surgical approaches in thyroid cancer and lymph-node metastases

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 22, Issue 6, 2008, Pages 971-987

  Dralle, Henning ^a   Machens, Andreas ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

lymph node dissection; thyroid cancer; thyroidectomy

Indexed keywords

FLUORODEOXYGLUCOSE; RADIOACTIVE IODINE;

BONE SCINTISCANNING; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; DISTANT METASTASIS; GOLD STANDARD; HISTOPATHOLOGY; HUMAN; LAPAROSCOPY; LIVER ANGIOGRAPHY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MEDICAL EXPERT; MICRODISSECTION; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROPHYLAXIS; RECURRENT CANCER; REOPERATION; REVIEW; RISK ASSESSMENT; SURGICAL APPROACH; THORACOSCOPY; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID SURGERY; THYROIDECTOMY; TREATMENT INDICATION; TUMOR VOLUME; UNNECESSARY PROCEDURE;

AGE FACTORS; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY, FOLLICULAR; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 56649100776     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2008.09.018     Document Type: Review

References (115)

1. British Thyroid Association. Guidelines for the management of thyroid cancer in adults. Available from:. http://www.british-thyroid-association.org
2. Dralle H. Evidence-based endocrine surgery: thyroid cancer. Editorial. World Journal of Surgery 31 (2007) 877-878
3. Machens A., Hauptmann S., and Dralle H. Referral bias in thyroid cancer surgery: direction and magnitude. European Journal of Surgical Oncology 34 (2008) 556-562
4. Cady B., and Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104 (1988) 947-953
5. Shaha A., Loree T.R., and Shah J.P. Intermediate-risk group for differentiated carcinoma of thyroid. Surgery 116 (1994) 1036-1041
6. Lang B.H.H., Chow S.M., Lo C.Y., et al. Staging systems for papillary thyroid carcinoma. Annals of Surgery 246 (2007) 114-121
7. In: Sobin L.H., and Ch W. (Eds). TNM classification of malignant tumors. 6th edn. (2002), Wiley-Liss, Inc.
8. Davies L., and Welch H.G. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA: The Journal of the American Medical Association 296 (2006) 2164-2167
9. Pacini F., Ladensohn P.W., Schlumberger M., et al. Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. The Journal of Clinical Endocrinology and Metabolism 91 (2006) 926-932
10. Thomusch O., Sekulla C., Walls G., et al. Analysis of surgery-related complications in thyroid carcinoma - a German prospective multicentre study with 275 patients. Acta Medica Austriaca 33 (2001) 194-198
11. Udelsman R., Lakatos E., and Ladenson P. Optimal surgery for papillary thyroid carcinomas. World Journal of Surgery 20 (1996) 88-93
12. Cooper D.S., Doherty G.M., Haugen B.R., et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16 (2006) 1-33
13. Dutch Association of Comprehensive Cancer Centres Thyroid Cancer. National evidence-based guideline. Available from:. http://www.oncoline.nl
14. Pacini F., Schlumberger M., Dralle H., et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. European Journal of Endocrinology 154 (2006) 787-803
15. Bilimoria K.Y., Bentrem D.J., Ko C.Y., et al. Extent of surgery affects survival for papillary thyroid cancer. Annals of Surgery 246 (2007) 375-384
16. Passler C., Scheuba C., Asari R., et al. Importance of tumor size in papillary and follicular thyroid cancer. The British Journal of Surgery 92 (2005) 184-189
17. LiVolsi V.A., Mozzaferri E.L., Schneider A.B., et al. Papillary carcinoma. In: DeLellis R.A., Lloyd R.V., Heitz P.U., et al. (Eds). Tumours of endocrine organs. Pathology and genetics. World Health Organization classification of tumours (2004), IARC Press, Lyon 57-66
18. Sobrinho-Simoes M., Noguchi S.U., Mazzaferri E.L., et al. In: DeLellis R.A., Lloyd R.V., and Heitz P.U. (Eds). Tumours of endocrine organs. Pathology and genetics. World Health Organization classification of tumours (2004), IARC Press, Lyon 67-72
19. Schmid K.W., and Farid N.R. How to define follicular thyroid carcinoma?. Virchows Archiv 448 (2006) 385-393
20. Schmid K.W., Tötsch M., Öfner D., et al. Minimally invasive follicular thyroid carcinoma: a clinico-pathological study. In: Schmid K.W., and Böcker W. (Eds). Thyroid pathology (1997), Springer, Berlin 37-43
21. Brennan M.D., Bergstralh E.J., v Heerden J.A., et al. Follicular thyroid cancer treated at the Mayo clinic 1946 through 1970: initial manifestions, pathologic, findings, therapy, and outcome. Mayo Clinic Proceedings 66 (1991) 11-22
22. van Heerden J.A., Hay I.D., Goellner J.R., et al. Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. Surgery 112 (1992) 1130-1138
23. Davis N.L., Bugis S.P., McGregor G.I., et al. An evaluation of prognostic scoring systems in patients with follicular thyroid cancer. American Journal of Surgery 170 (1995) 476-480
24. DeGroot L.J., Kaplan E.L., Shukla M.S., et al. Morbidity and mortality in follicular thyroid cancer. The Journal of Clinical Endocrinology and Metabolism 80 (1995) 2946-2953
25. Shaha A.R., Loree T.R., and Shah J.P. Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 118 (1995) 1131-1138
26. Rao R.S., Parikh H.K., Deshmane V.H., et al. Prognostic factors in follicular carcinoma of the thyroid: a study of 198 cases. Head & Neck 18 (1996) 118-126
27. Saadi H., Kleidermacher P., and Esselstyn C. Conservative management of patients with intrathyroidal well-differentiated follicular thyroid carcinoma. Surgery 130 (2001) 30-35
28. Chow S.M., Law S.C.K., Mendenhall W.M., et al. Follicular thyroid carcinoma. Cancer 95 (2002) 488-498
29. Witte J., Goretzki P.E., Diaken J., et al. Importance of lymph node metastases in follicular thyroid cancer. World Journal of Surgery 26 (2002) 1017-1022
30. D'Avanzo A., Treseler P., Ituarte P.H.G., et al. Follicular thyroid carcinoma: histology and prognosis. Cancer 100 (2004) 1123-1129
31. Furlan J.C., Bedard Y.C., and Rosen I.B. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinoma. Journal of the American College of Surgeons 198 (2004) 341-348
32. Passler C., Scheuba C., Prager G., et al. Prognostic factors of papillary and follicular cancer: differences in an iodine-replete endemic goiter region. Endocrine-Related Cancer 11 (2004) 131-139
33. Besic N., Zgajnar J., Hocevar M., et al. Is patients' age a prognostic factor for follicular thyroid carcinoma in the TNM classification system?. Thyroid 15 (2005) 439-448
34. Lo C.Y., Chan W.F., Lam K.Y., et al. Follicular thyroid carcinoma. The role of histology and staging systems in predicting survival. Annals of Surgery 242 (2005) 708-715
35. Furlan J.C., Bedard Y.C., and Rosen I.B. Significance of tumor capsular invasion in well-differentiated thyroid carcinomas. The American Surgeon 73 (2007) 484-491
36. Shaha A. Invited commentary: minimally invasive follicular thyroid carcinoma. Surgery 130 (2001) 119-120
37. Delbridge L., Barraclough B., Parkyn R., et al. Minimally invasive follicular thyroid carcinoma: completion thyroidectomy or not?. ANZ Journal of Surgery 72 (2002) 844-845
38. Farahati J., Reiners C., and Demidchik E.P. Is the UICC/AJCC classification of primary tumor in childhood thyroid carcinoma valid?. Journal of Nuclear Medicine 40 (1999) 2125
39. Leboulleux S., Baudin E., Hartl D., et al. Follicular cell-derived thyroid cancer in children. Hormone Research 63 (2005) 145-151
40. Elisei R., Bottici V., Luchetti F., et al. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10.894 patients with nodular thyroid disorders. The Journal of Clinical Endocrinology and Metabolism 89 (2004) 163-168
41. Miyauchi A., Matsuzuka F., Hivai K., et al. Unilateral surgery supported by germline RET oncogene mutation analysis in patients with sporadic medullary thyroid carcinoma. World Journal of Surgery 24 (2000) 1367-1372
42. Peix J.L., Braun P., Saachat M., et al. Occult micro medullary thyroid carcinoma: therapeutic strategy and follow-up. World Journal of Surgery 24 (2000) 1373-1376
43. Machens A., Gimm O., Ukkat J., et al. Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis. Cancer 88 (2000) 1909-1915
44. Machens A., Hinze R., Thomusch O., et al. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World Journal of Surgery 26 (2002) 22-28
45. Machens A., Hinze R., Lautenschläger C., et al. Multivariate analysis of clinicopathologic parameters for the insular subtype of differentiated thyroid carcinoma. Archives of Surgery 136 (2001) 941-944
46. Hiltzik D., Carlson D.L., Tuttle R.M., et al. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis. Cancer 106 (2006) 1286-1295
47. Pellegriti G., Giuffrida D., Scollo C., et al. Long-term outcome of patients with insular carcinomas of the thyroid. Cancer 95 (2002) 2076-2085
48. Machens A., Lautenschläger C., Thomusch O., et al. Extended surgery and early postoperative radiotherapy for undifferentiated thyroid carcinoma. Thyroid 11 (2001) 373-380
49. Lang B.H.H., and Lo C.Y. Surgical options in undifferentiated thyroid carcinoma. World Journal of Surgery 31 (2007) 969-977
50. Machens A., Hinze R., Lautenschläger C., et al. Thyroid carcinoma invading the cervicovisceral axis: routes of invasion and clinical implications. Surgery 129 (2001) 23-28
51. Robbins K.T., Medina J.E., Wolfe G.T., et al. Standardizing neck dissection terminology. Archives of Otolaryngology--Head & Neck Surgery 117 (1991) 601-605
52. Robbins K.T., Clayman G., Levine P.A., et al., the Committee for Head and Neck Surgery and Oncology, American Academy of Otolaryngology-Head and Neck Surgery. Neck dissection classification update. Archives of Otolaryngology--Head & Neck Surgery 128 (2002) 751-758
53. Qubain S.W., Nakano S., Baba M., et al. Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery 131 (2002) 249-256
54. Ch W., Greene F.L., Henson D.E., et al. TNM supplement. 3rd edn. (2003), Wiley-Liss, New York 25-30
55. Dralle H., Damm I., Scheumann G.F.W., et al. Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surgery Today 24 (1994) 112-121
56. Dralle H., and Gimm O. Lymphadenektomie beim Schilddrüsenkarzinom. Der Chirurg 67 (1996) 788-806
57. Goropoulos A., Karamoshos K., Christodoulou A., et al. Value of the cervical compartments in the surgical treatment of papillary thyroid carcinoma. World Journal of Surgery 28 (2004) 1275-1281
58. Leboulleux S., Rubino C., Baudin E., et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. The Journal of Clinical Endocrinology and Metabolism 90 (2005) 5723-5729
59. Ito Y., Jikuzono T., Higashiyama T., et al. Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World Journal of Surgery 30 (2006) 1821-1828
60. Vasko V., Hu S., Wu G., et al. High prevalence and possible de novo formation of BRAF mutation in metastasized papillary thyroid cancer in lymph nodes. The Journal of Clinical Endocrinology and Metabolism 90 (2005) 5265-5269
61. Ito Y., Uruno T., Takamura Y., et al. Papillary microcarcinomas of the thyroid with preoperatively detectable lymph node metastasis show significantly higher aggressive characteristics on immuno-histochemical examination. Oncology 68 (2005) 87-96
62. Machens A., Holzhausen H.J., Lautenschläger C., et al. Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma. Cancer 98 (2003) 712-719
63. Scheumann G.F.W., Gimm O., Wegener G., et al. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World Journal of Surgery 18 (1994) 559-568
64. Sugitani I., Kasai N., Fujimoto Y., et al. A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 135 (2004) 139-148
65. Ito Y., and Miyauchi A. Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks. World Journal of Surgery 31 (2007) 905-915
66. White M.L., Gauger P.G., and Doherty G.M. Central lymph node dissection in differentiated thyroid cancer. World Journal of Surgery 31 (2007) 895-904
67. Ito Y., Tomoda C., Uruno T., et al. Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World Journal of Surgery 30 (2006) 91-99
68. Wada N., Duh Q.Y., Sugino K., et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas. Annals of Surgery 237 (2003) 399-407
69. Pereira J.A., Jimeno J., Miquel J., et al. Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery 138 (2005) 1095-1101
70. Lee Y.S., Kim S.W., Kang H.S., et al. Extent of routine central lymph node dissection with small papillary thyroid carcinoma. World Journal of Surgery 31 (2007) 1954-1959
71. Ito Y., Tomoda C., Uruno T., et al. Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid. World Journal of Surgery 28 (2004) 498-501
72. Ito Y., Tomoda C., Uruno T., et al. Papillary microcarcinoma of the thyroid: how should it be treated?. World Journal of Surgery 28 (2004) 1115-1121
73. Ito Y., Tomoda C., Uruno T., et al. Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World Journal of Surgery 29 (2005) 917-920
74. Ito Y., Higashiyama T., Takamura Y., et al. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World Journal of Surgery 31 (2007) 2085-2091
75. Sywak M., Cornfod L., Roach P., et al. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 140 (2006) 1000-1007
76. Henry J.F., Gramatica L., Denizot A., et al. Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma. Langenbeck's Archives of Surgery 383 (1998) 167-169
77. Skinner M.A., Moley J.A., Dilley W.G., et al. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. The New England Journal of Medicine 353 (2005) 1105-1113
78. Roh J.L., Park J.Y., and Park C.I. Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients. Annals of Surgery 245 (2007) 604-610
79. Cheah W.K., Arici C., Ituarte P.H.G., et al. Complications of neck dissection for thyroid cancer. World Journal of Surgery 26 (2002) 1013-1016
80. Short S.O., Kaplan J.N., Laramore G.E., et al. Shoulder pain and function after neck dissection with or without preservation of the spinal accessory nerve. American Journal of Surgery 148 (1984) 478-482
81. Dralle H., Scheumann G.F.W., Hundeshagen H., et al. Die transsternale zervikomediastinale Primärtumorresektion und Lymphadenektomie beim Schilddrüsenkarzinom. Langenbeck's Archives of Surgery 377 (1992) 34-44
82. Sugenoya A., Asanuma K., Shingu K., et al. Clinical evaluation of upper mediastinal dissection for differentiated thyroid carcinoma. Surgery 113 (1993) 541-544
83. Feind C.R., and Cole R.M. Contralateral spread of head and neck cancer. American Journal of Surgery 118 (1969) 660-665
84. Lam K.Y.A., and Yau Lo C. Diffuse sclerosing variant of papillary carcinoma of the thyroid: a 35-year comparative study at a single institution. Annals of Surgery Oncology 13 (2006) 176-181
85. Sanders L.E., and Silverman M. Follicular and Hürthle cell carcinoma: predicting outcome and directing therapy. Surgery 124 (1998) 967-974
86. Haigh P.I., and Urbach D.R. The treatment and prognosis of Hürthle cell follicular thyroid carcinoma compared with its non-Hürthle cell counterpart. Surgery 138 (2005) 1152-1158
87. Sobrinho-Simoes M., Albores-Saavedra J., Tallini G., et al. Poorly differentiated carcinoma. Pathology and Genetics of Tumors of Endocrine Organs. In: DeLellis R. (Ed). RV Lloyd, PU Heitz, C Eng (2004), IARC Press, Lyon 73
88. Pulcrano M., Boukheris H., Talbot M., et al. Poorly differentiated follicular thyroid carcinoma: prognostic factors and relevance of histological classification. Thyroid 17 (2007) 639-646
89. Kebebew E., Greenspan F.S., Clark O.H., et al. Anaplastic thyroid carcinoma. Cancer 103 (2005) 1330-1335
90. Machens A., Schneyer U., Holzhausen H.J., et al. Prospects of remission in medullary thyroid carcinoma according to basal calcitionin level. The Journal of Clinical Endocrinology and Metabolism 90 (2005) 2029-2034
91. Schlumberger M.J. Papillary and follicular thyroid carcinoma. The New England Journal of Medicine 338 (1998) 297-306
92. Machens A., Hofmann C., Hauptmann S., et al. Locoregional recurrence and death from medullary thyroid carcinoma in a contemporaneous series: 5-year results. European Journal of Endocrinology 157 (2007) 85-93
93. Kebebew E., Greenspan F.S., Clark O.H., et al. Extent of disease and practice patterns for medullary thyroid cancer. Journal of the American College of Surgeons 200 (2005) 890-896
94. Moley J.F., and Fialkowski E.A. Evidence-based approach to the management of sporadic medullary thyroid carcinoma. World Journal of Surgery 31 (2007) 946-956
95. Modigliani E., Cohen R., Campos J.M., et al., the GETC Study Group. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. Clinical Endocrinology 48 (1998) 265-273
96. Scollo C., Baudin E., Travagli J.P., et al. Rationale for central und bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. The Journal of Clinical Endocrinology and Metabolism 88 (2003) 2070-2075
97. Machens A., Hauptmann S., and Dralle H. Prediction of lateral lymph node metastases in medullary thyroid cancer. The British Journal of Surgery 95 (2008) 586-591
98. Machens A., Hauptmann S., and Dralle H. Increased risk of lymph node metastasis in multifocal hereditary and sporadic medullary thyroid cancer. World Journal of Surgery 31 (2007) 1960-1965
99. Machens A., Holzhausen H.J., and Dralle H. Prediction of mediastinal lymph node metastasis in medullary thyroid carcinoma. The British Journal of Surgery 91 (2004) 709-712
100. Machens A., Holzhausen H.J., and Dralle H. Contralateral cervical and mediastinal lymph node metastasis in medullary thyroid cancer: systemic disease?. Surgery 139 (2006) 28-32
101. Dralle H., Scheumann G.F.W., Proye C., et al. The value of lymph node dissection in hereditary medullary thyroid carcinoma: a retrospective, European, multicentric study. Journal of Internal Medicine 238 (1995) 357-361
102. Machens A., Niccoli-Sire P., Hoegel J., et al. Early malignant progression of hereditary medullary thyroid carcinoma. The New England Journal of Medicine 349 (2003) 1517-1525
103. Machens A., Ukkat J., Brauckhoff M., et al. Advances in the management of hereditary medullary thyroid cancer. Journal of Internal Medicine 257 (2005) 50-59
104. Niccoli-Sire P., Murat A., Rohmer V., et al. French Calcitonin Tumors Study Group (GETC). Familial medullary thyroid carcinoma with noncysteine RET mutations: phenotype-genotype relationship in a large series of patients. The Journal of Clinical Endocrinology and Metabolism 86 (2001) 3746-3753
105. Dralle H., Gimm O., Simon D., et al. Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience. World Journal of Surgery 22 (1998) 744-751
106. Ukkat J., Lorenz K., Hinze R., et al. Importance of early screening and prophylactic thyroidectomy in asymptomatic nonindex RET germline carriers. World Journal of Surgery 25 (2001) 713-717
107. Gimm O., Ukkat J., Niederle B.E., et al. Timing and extent of surgery in patients with familial medullary thyroid carcinoma/multiple endocrine neoplasia 2A-related RET mutations not affecting codon 634. World Journal of Surgery 28 (2004) 1312-1316
108. Yip L., Cote G.J., Shapiro S.E., et al. Multiple endocrine neoplasia type 2. Archives of Surgery 138 (2003) 409-416
109. Brandi M.L., Gagel R.F., Angeli A., et al. Consensus. Guidelines for diagnosis and therapy of MEN type 1 and type 2. The Journal of Clinical Endocrinology and Metabolism 86 (2001) 5658-5671
110. Moley J.F., Wells S.A., Dilley W.G., et al. Reoperation for recurrent or persistent medullary thyroid cancer. Surgery 114 (1993) 1090-1096
111. Gimm O., and Dralle H. Reoperation in metastasizing medullary thyroid carcinoma: is a tumor stage-oriented approach justified?. Surgery 122 (1997) 1124-1131
112. Gimm O., Ukkat J., and Dralle H. Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma. World Journal of Surgery 22 (1998) 562-568
113. Chen H., Robert J.R., Ball D.W., et al. Effective long-term palliation of symptomatic, incurable metastatic medullary thyroid cancer by operative resection. Annals of Surgery 227 (1998) 887-895
114. Machens A., Gimm O., Ukkat J., et al. Repeat mediastinal lymph-node dissection for palliation in advanced medullary thyroid carcinoma. Langenbeck's Archives of Surgery 384 (1999) 271-276
115. Kouvaraki M.A., Lee J.E., Shapiro S.E., et al. Preventable reoperations for persistent and recurrent papillary thyroid carcinoma. Surgery 136 (2004) 1189-1191